Simvastatin and Verapamil Interaction

Drug interaction information between Simvastatin and Verapamil.

Simvastatin and Verapamil have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Simvastatin and Verapamil. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Simvastatin

HMG-CoA Reductase Inhibitor (Statin)

Drug B

Verapamil

Calcium Channel Blocker

How They Interact

Verapamil slows down the process your body uses to get rid of simvastatin, which can cause the drug to reach toxic levels. This increases the risk of serious muscle injury.

FDA Label Information

Intervention: For patients taking verapamil, diltiazem, or dronedarone, do not exceed ezetimibe and simvastatin 10 mg/10 mg daily.

Frequently Asked Questions

What SPL severity band is on file for Simvastatin + Verapamil?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Verapamil has 57 labeled pairs on file vs Simvastatin's 41. In the major band specifically: Simvastatin has 11 (also Diltiazem, Cyclosporine, Amiodarone, Dronedarone); Verapamil has 4 (also Eplerenone, Ezetimibe, Ezetimibe/Simvastatin).

What mechanism field is on file for Simvastatin and Verapamil?

Verapamil slows down the process your body uses to get rid of simvastatin, which can cause the drug to reach toxic levels. This increases the risk of serious muscle injury.

Simvastatin carries more major-labeled pairs than Verapamil

SPL source-record counts only. This page's band is major · classes on file: Simvastatin (HMG-CoA Reductase Inhibitor (Statin)); Verapamil (Calcium Channel Blocker).

Simvastatin has 11 major-labeled pairs vs Verapamil's 4.

Simvastatin

11 major · 9 moderate · 21 minor · 41 total

Verapamil

4 major · 6 moderate · 47 minor · 57 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.